title: Reply to L.k. Griffeth et al and J.E. Battley et al.
authors.affiliation: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA lschnipp@bidmc.harvard.edu.
authors.forename: Lowell E
authors.initials: LE
authors.lastname: Schnipper
authors.affiliation: American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Richard L
authors.initials: RL
authors.lastname: Schilsky
authors.affiliation: US Oncology Network, The Woodlands, TX.
authors.forename: J Russell
authors.initials: JR
authors.lastname: Hoverman
authors.affiliation: Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.
authors.forename: Derek
authors.initials: D
authors.lastname: Raghavan
authors.affiliation: Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, WA.
authors.forename: Gary H
authors.initials: GH
authors.lastname: Lyman
authors.affiliation: American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Dana S
authors.initials: DS
authors.lastname: Wollins
authors.affiliation: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.
authors.forename: Douglas W
authors.initials: DW
authors.lastname: Blayney
mesh_terms: D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D010818:Practice Patterns, Physicians' / Q000592:standards*; D012955:Societies, Medical / Q000592:standards*